The Role of VPS35 in the Pathobiology of Parkinson's Disease
- PMID: 32323152
- PMCID: PMC11448700
- DOI: 10.1007/s10571-020-00849-8
The Role of VPS35 in the Pathobiology of Parkinson's Disease
Abstract
The vacuolar protein sorting 35 (VPS35) gene located on chromosome 16 has recently emerged as a cause of late-onset familial Parkinson's disease (PD) (PARK17). The gene encodes a 796-residue protein nearly ubiquitously expressed in human tissues. The protein localizes on endosomes where it assembles with other peripheral membrane proteins to form the retromer complex. How VPS35 mutations induce dopaminergic neuron degeneration in humans is still unclear. Because the retromer complex recycles the receptors that mediate the transport of hydrolase to lysosome, it has been suggested that VPS35 mutations lead to impaired lysosomal and autophagy function. Recent studies also demonstrated that VPS35 and the retromer complex influence mitochondrial homeostasis, suggesting that VPS35 mutations elicit mitochondrial dysfunction. More recent studies have identified a key role of VPS35 in neurotransmission, whilst others reported a functional interaction between VPS35 and other genes associated with familial PD, including α-SYNUCLEIN-PARKIN-LRRK2. Here, we review the biological role of VPS35 protein, the VPS35 mutations identified in human PD patients, and the potential molecular mechanism by which VPS35 mutations can induce progressive neurodegeneration in PD.
Keywords: PARK17; Parkinson’s disease; Retromer complex; VPS35.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
References
-
- Ando M, Funayama M, Li Y et al (2012) VPS35 mutation in Japanese patients with typical Parkinson’s disease. Mov Disord 27:1413–1417. 10.1002/mds.25145 - PubMed
-
- Birmingham CL, Smith AC, Bakowski MA et al (2006) Autophagy controls Salmonella infection in response to damage to the Salmonella-containing vacuole. J Biol Chem. 10.1074/jbc.M509157200 - PubMed
-
- Blanckenberg J, Ntsapi C, Carr JA, Bardien S (2014) EIF4G1 R1205H and VPS35 D620N mutations are rare in Parkinson’s disease from South Africa. Neurobiol Aging. 10.1016/j.neurobiolaging.2013.08.023 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
